Sanofi Gets Rival's Patent For Rare Disease Nixed At EPO
Sanofi has convinced European officials to nix a German rival's patent for diagnosing a rare genetic disease because it didn't properly explain how scientists would detect one small target molecule out...To view the full article, register now.
Already a subscriber? Click here to view full article